Source: http://thefederalregister.com/2008/09/26/E8-22592.html
Timestamp: 2019-07-20 13:26:10
Document Index: 524154214

Matched Legal Cases: ['§ 422', '§ 423', '§ 422', '§ 423', '§ 423', '§ 423', '§ 422', '§ 423', '§ 422', '§ 423', '§ 423', '§ 423', '§ 423', '§ 423', '§ 423', '§ 423', '§ 422', '§ 423', '§ 423', '§ 423', '§ 422', '§ 423', '§ 422', '§ 423', 'arts 422', 'arts 422', 'ART 422', 'art 422', 'ART 423', 'art 423']

Federal Register | Medicare Program; Revisions to the Medicare Advantage and Par
[CMS-4124-F2]
RIN-0938-AO78
SUMMARY: In the December 5, 2007 issue of theFederal Register, we published a final rule finalizing the Medicare program provisions relating to contract determinations involving Medicare Advantage (MA) organizations and Medicare Part D prescription drug plan sponsors, including eliminating the reconsideration process for review of contract determinations, revising the provisions related to appeals of contract determinations, and clarifying the process for MA organizations and Part D sponsors to complete corrective action plans. In that final rule, we also clarified the intermediate sanction and civil money penalty provisions that apply to MA organizations and Part D sponsors, modified elements of MA organizations and Part D sponsors' compliance plans, retained voluntary self-reporting for Part D sponsors, implemented voluntary self-reporting for MA organizations, and revised provisions to ensure HHS has access to the books and records of MA organizations and Part D sponsors' first tier, downstream, and related entities. This correcting amendment corrects a limited number of technical and typographical errors identified in the December 5, 2007 final rule.
DATES: These correcting amendments are effective September 26, 2008, except for the amendment to SS 423.505, which is effective on January 1, 2009. The correcting amendments for SS 422.756(d) and SS 423.756(d) are applicable beginning January 4, 2008.
FOR FURTHER INFORMATION CONTACT: Christine Reinhard (410) 786-2987. Stephanie Blaydes Kaisler (410) 786-0957.
In FR Doc. 07-5946 (72 FR 68700 through 68741), the final rule entitled, “Revisions to the Medicare Advantage and Part D Prescription Drug Contract Determinations, Appeals, and Intermediate Sanctions Processes,” there were technical errors that have been identified and corrected in the regulations text of this correcting amendment. We note that correcting two of these technical errors, found at § 422.756(d) and § 423.756(d), ensure that certain existing provisions which were never intended to be the subject of notice and comment rulemaking, remain in place for the benefit of all affected parties, including MA organizations and Part D sponsors. The provisions in this correcting amendment for § 422.756(d) and § 423.756(d) are effective as if they were included in the final rule published December 5, 2007. Accordingly, the corrections are effective retroactive to January 4, 2008, the effective date of most of the provisions of the final rule. However, the provisions in this correcting amendment for § 423.505 are effective January 1, 2009 since these particular provisions in § 423.505 were not set to take effect until January 1, 2009.
On pages 68726 and 68735 of the December 5, 2007 final rule, there were technical errors made in the regulation text of § 422.756(d) and § 423.756(d). Specifically, a typographical error in our amendatory instructions caused us to inadvertently omit from the Code of Federal Regulations (CFR) existing paragraphs § 422.756(d)(3) and § 423.756(d)(3) regarding the duration of an MA and Part D intermediate sanction, respectively. We note that these existing provisions were not intended to be revised in the December 5, 2007 final rule (72 FR 68700 through 68741).
On page 68732 of the December 5, 2007 final rule, our amendatory instruction indicated that we were revising § 423.505(i)(2)(i). However, when we set out the changed regulations text, we inadvertently revised paragraph (i)(2)(ii) instead of paragraph (i)(2)(i). This typographical error, if not corrected, would have inadvertently deleted from the CFR the current paragraph at § 423.505(i)(2)(ii) regarding the 10-year record retention requirement as of January 1, 2009, the effective date of this provision as specified in the final rule. The correct § 423.505(i)(2)(i) should read “HHS, the Comptroller General, or their designeeshave the right to audit, evaluate and inspect any books, contracts, records, including medical records, and documentation of the first tier, downstream, and related entities involving transactions related to CMS' contract with the Part D sponsor.” As stated above, the existing § 423.505(i)(2)(ii), which references the 10-year record retention requirements, remains in the CFR unchanged.
In § 423.505(i)(3)(iii) the term “related entity” is incorrectly used twice in the same sentence, so we have removed this duplication. In addition, we inadvertently included MA organization in § 423.505(i)(3)(iv) which only applies to Part D sponsors. We have revised the language accordingly.
The provisions of this correcting amendment regarding the duration of sanctions at § 422.756(d) and § 423.756(d) make no substantive changes and are intended to restore provisions which were inadvertently removed from the CFR. These provisions were not revised in the final rule but were dropped because of a typographical error in our amendatory instructions. We must reinstate these provisions in the CFR to ensure that CMS may lift sanctions on MA and Part D plans as appropriate.
In addition, a typographical error in our regulations text would have inadvertently removed the current § 423.505(i)(2)(ii) from the CFR as of the effective date for these provisions on January 1, 2009. We are taking this opportunity to correct this error in the CFR to ensure that the 10-year record retention requirements for Part D sponsors remains in the CFR unchanged. Without this correcting amendment, the Medicare Part D regulations could have been construed as being silent on the 10-year Part D recordkeeping requirement which could create confusion and uncertainty for affected parties regarding CMS' policy on this issue.
Finally, we are also taking this opportunity to correct typographical errors in § 423.505(i)(3)(iii) and (iv).
For the same reasons, we are also waiving the 30-day delay in effective date for § 422.756(d) and § 423.756(d) in this correcting amendment. We believe that it is in the public interest to ensure that the December 5, 2007 final rule accurately state the current law and CMS policy. Thus, delaying the effective date of these corrections would be contrary to the public interest. Therefore, we also find good cause to waive the 30-day delay in effective date for § 422.756(d) and § 423.756(d).
List of Subjects 42 CFR Parts 422 and 423 Accordingly, 42 CFR chapter IV is corrected by making the following correcting amendments to parts 422 and 423. PART 422—MEDICARE ADVANTAGE PROGRAM 1. The authority citation for part 422 continues to read as follows: Authority:
(3)Duration of sanction.The sanction remains in effect until CMS notifies the MA organization that CMS is satisfied that the basis for imposing the sanction has been corrected and is not likely to recur.
PART 423—VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT 3. The authority citation for part 423 continues to read as follows: Authority:
4. Section 423.505 is amended by— A. Revising paragraph (i)(2)(i). B. Revising paragraph (i)(2)(ii). C. Revising paragraph (i)(3)(iii). D. Revising paragraph (i)(3) (iv).
(3)Duration of sanction.The sanction remains in effect until CMS notifies the Part D sponsor that CMS is satisfied thatthe basis for imposing the sanction is corrected and is not likely to recur.
Dated: September 16, 2008. Ann C. Agnew, Executive Secretary to the Department.